Detalhe da pesquisa
1.
Low-affinity immunoglobulin gamma Fc region receptor III-B (FcγRIIIB, CD16B) deficiency in patients with blood and immune system disorders.
Br J Haematol
; 195(5): 743-747, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34544201
2.
Proliferation to Apoptosis Tumor Cell Ratio as a Biomarker to Improve Clinical Management of Pre-Malignant and Symptomatic Plasma Cell Neoplasms.
Int J Mol Sci
; 22(8)2021 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33918790
3.
Clonal heterogeneity and genomic evolution in intrachromosomal amplification of chromosome 21: A case report.
Br J Haematol
; 204(6): 2512-2515, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38665061
4.
Safety and efficacy of bosutinib in fourth-line therapy of chronic myeloid leukemia patients.
Ann Hematol
; 98(2): 321-330, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30446802
5.
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program.
Am J Hematol
; 90(5): 429-33, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25683327
6.
Blood-based risk stratification for pre-malignant and symptomatic plasma cell neoplasms to improve patient management.
Am J Cancer Res
; 11(6): 2736-2753, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34249425
7.
Predictive value of 1q21 gain in multiple myeloma is strongly dependent on concurrent cytogenetic abnormalities and first-line treatment.
Am J Cancer Res
; 11(9): 4438-4454, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34659897
8.
Correction: Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition.
Oncotarget
; 9(67): 32881, 2018 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30214691
9.
Overexpression of KIR inhibitory ligands (HLA-I) determines that immunosurveillance of myeloma depends on diverse and strong NK cell licensing.
Oncoimmunology
; 5(4): e1093721, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27141379
10.
[Mutation of MTHFR gene as marker of endothelial dysfunction in patients diagnosed of migraine with aura]. / Mutación del gen MTHFR como marcador de disfunción endotelial en pacientes diagnosticados de migraña con aura.
Med Clin (Barc)
; 132(12): 484, 2009 Apr 04.
Artigo
em Espanhol
| MEDLINE | ID: mdl-19344796
11.
The gene expression response of chronic lymphocytic leukemia cells to IL-4 is specific, depends on ZAP-70 status and is differentially affected by an NFκB inhibitor.
PLoS One
; 9(10): e109533, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25280001